INDACO VENTURE PARTNERS INVESTS IN SERIES B OF GENESPIRE
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into
INDACO VENTURE PARTNERS SEEDS MICROBIAL DERIVED ONCOLOGY THERAPEUTICS COMPANY, MICTHERA
Milan, May 30th 2024 – Indaco Venture Partners is pleased to announce its first technology transfer investment into MicThera
INDACO VENTURE PARTNERS – NOUSCOM RAISES €67.5 MILLION ($72 MILLION) IN OVERSUBSCRIBED SERIES C FINANCING ROUND
Milano, 14 November 2023 – Indaco Venture Partners SGR, one of the largest independent Italian venture capital asset management
INDACO VENTURE PARTNERS – FREYA BIOSCIENCES RAISES USD 38 MILLION IN A SERIES A TO ADVANCE GROUND BREAKING IMMUNOTHERAPY PLATFORM TARGETING VAGINAL MICROBIOTA
Milano, 12 December 2023 – Indaco Venture Partners SGR, one of the largest independent Italian venture capital asset management company
INDACO VENTURE PARTNERS – HOBA THERAPEUTICS RAISES EUR 23 MILLION IN A SERIES A TO ADVANCE NEW DRUG CANDIDATE AGAINST CHORNIC NEUROPATHIC PAIN
Milano, 11 December 2023 – Indaco Venture Partners SGR, one of the largest independent Italian venture capital asset management company
INDACO VENTURE PARTNERS – PRIMO INVESTIMENTO DEL FONDO INDACO BIO NEL ROUND DI FINANZIAMENTO DI 23 MILIONI DI EURO IN SIBYLLA BIOTECH
Milano, 4 ottobre 2022 – Indaco Venture Partners SGR, uno dei principali operatori indipendenti italiani di venture capital, annuncia oggi